Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Robert J. Holt, John G. Fort, Amy Y. Grahn, Jeffrey D. Kent & Alfonso E. Bello. (2015) Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. The Physician and Sportsmedicine 43:3, pages 200-212.
Read now
Read now
Allan Gibofsky, Marc C. Hochberg, Mark J. Jaros & Clarence L. Young. (2014) Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Current Medical Research and Opinion 30:9, pages 1883-1893.
Read now
Read now
Jeffery D. Kent, Robert J. Holt, Donald Jung, George F. Tidmarsh, Amy Y. Grahn, Julie Ball & David A. Peura. (2014) Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysis. Journal of Drug Assessment 3:1, pages 20-27.
Read now
Read now
Catherine Datto, Richard Hellmund & Mohd Kashif Siddiqui. (2013) Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses. Open Access Rheumatology: Research and Reviews 5, pages 1-19.
Read now
Read now
Roy Altman, Stephen Daniels & Clarence L. Young. (2013) Indomethacin Submicron Particle Capsules Provide Effective Pain Relief in Patients with Acute Pain: A Phase 3 Study. The Physician and Sportsmedicine 41:4, pages 7-15.
Read now
Read now
Allan Gibofsky, Stephen Silberstein, Charles Argoff, Stephen Daniels, Steve Jensen & Clarence L. Young. (2013) Lower-Dose Diclofenac Submicron Particle Capsules Provide Early and Sustained Acute Patient Pain Relief in a Phase 3 Study. Postgraduate Medicine 125:5, pages 130-138.
Read now
Read now
Bill McCarberg & Penny Tenzer. (2013) Complexities in the pharmacologic management of osteoarthritis pain. Current Medical Research and Opinion 29:5, pages 539-548.
Read now
Read now
Byron L. Cryer, Mark B. Sostek, John G. Fort, Ola Svensson, Clara Hwang & Marc C. Hochberg. (2011) A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials. Annals of Medicine 43:8, pages 594-605.
Read now
Read now
Sanford H. Roth & Shane Anderson. (2011) The NSAID Dilemma: Managing Osteoarthritis in High-Risk Patients. The Physician and Sportsmedicine 39:3, pages 62-74.
Read now
Read now
Articles from other publishers (36)
Mart A. F. J. van de Laar, Rainer Schöfl, Marlou Prevoo & Jan Jastorff. (2023) Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials. PLOS ONE 18:4, pages e0284358.
Crossref
Crossref
Joseph Pergolizzi, Giustino Varrassi, Jo Ann K LeQuang, Frank Breve & Peter Magnusson. (2023) Fixed Dose Versus Loose Dose: Analgesic Combinations. Cureus.
Crossref
Crossref
Yura Kim, Gregory Levin, Nikolay P. Nikolov, Robert Abugov & Rebecca Rothwell. (2022) Concept End Points Informing Design Considerations for Confirmatory Clinical Trials in Osteoarthritis. Arthritis Care & Research 74:7, pages 1154-1162.
Crossref
Crossref
Hyungdon Kook, Cheol Woong Yu, Donghoon Choi, Tae Hoon Ahn, Kiyuk Chang, Jin-Man Cho, Soo-Joong Kim, Chang Gyu Park, Deok-Kyu Cho, Sang-Hyun Kim, Han Cheol Lee, Han-Young Jin, In-Ho Chae, Kihwan Kwon, Sung Gyun Ahn, Ju Han Kim, Sang-Rok Lee, Jeong-Su Kim, Seok Yeon Kim & Sang Wook Lim. (2022) Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial. Clinical Therapeutics 44:4, pages 508-528.
Crossref
Crossref
Dong-Wook Kim & Kwon Yeon Weon. (2021) Pharmaceutical application and development of fixed-dose combination: dosage form review. Journal of Pharmaceutical Investigation 51:5, pages 555-570.
Crossref
Crossref
Man Soo Kim, In Jun Koh, Yong Gyu Sung, Dong Chul Park, Sung Cheol Yang & Yong In. (2021) Efficacy and safety of celecoxib combined with JOINS in the treatment of degenerative knee osteoarthritis: study protocol of a randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110240.
Crossref
Crossref
Rex Park, Anthony M.-H. Ho, Gisele Pickering, Lars Arendt-Nielsen, Mohammed Mohiuddin & Ian Gilron. (2020) Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Anesthesia & Analgesia 131:3, pages 764-775.
Crossref
Crossref
M.V. Bielsa-Fernández, J.L. Tamayo-de la Cuesta, J. Lizárraga-López, J.M. Remes-Troche, R. Carmona-Sánchez, J.M. Aldana-Ledesma, J.M. Avendaño-Reyes, M.A. Ballesteros-Amozorrutia, M. De Ariño, L. de Giau-Triulzi, R. Flores-Rendón, H. Huerta-Guerrero, J.A. González-González, A. Hernández-Guerrero, E. Murcio-Pérez, J. Jáquez-Quintana, A. Meixueiro-Daza, J.R. Nogueira-de Rojas, H. Rodríguez-Hernández, R. Santoyo-Valenzuela, S.C. Solorzano-Olmos, L.F. Uscanga-Domínguez & F. Zamarripa-Dorsey. (2020) The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathy. Revista de Gastroenterología de México (English Edition) 85:2, pages 190-206.
Crossref
Crossref
M.V. Bielsa-Fernández, J.L. Tamayo-de la Cuesta, J. Lizárraga-López, J.M. Remes-Troche, R. Carmona-Sánchez, J.M. Aldana-Ledesma, J.M. Avendaño-Reyes, M.A. Ballesteros-Amozorrutia, M. De Ariño, L. de Giau-Triulzi, R. Flores-Rendón, H. Huerta-Guerrero, J.A. González-González, A. Hernández-Guerrero, E. Murcio-Pérez, J.O. Jáquez-Quintana, A. Meixueiro-Daza, J.R. Nogueira-de Rojas, H. Rodríguez-Hernández, R. Santoyo-Valenzuela, S.C. Solorzano-Olmos, L.F. Uscanga-Domínguez & F. Zamarripa-Dorsey. (2020) Consenso mexicano sobre diagnóstico, prevención y tratamiento de la gastropatía y enteropatía por antiinflamatorios no esteroideos. Revista de Gastroenterología de México 85:2, pages 190-206.
Crossref
Crossref
Min-Gyue Park, Jae-Doo Yoo & Kyu-Ho Lee. (2020) Current Guidelines for Non-Steroidal Anti-Inflammatory Drugs. Journal of the Korean Orthopaedic Association 55:1, pages 9.
Crossref
Crossref
Daehyun ParkYonguk Kwon. (2020) Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug. Clinics in Orthopedic Surgery 12:1, pages 86.
Crossref
Crossref
Claire L. Smith, Yan Jin, Eyas Raddad, Terry A. McNearney, Xiao Ni, David Monteith, Roger Brown, Mark A. Deeg & Thomas Schnitzer. (2019) Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis. Pharmaceutical Statistics 18:1, pages 39-53.
Crossref
Crossref
Daniel Sowah, Flora Balat & Sebastian Straube. (2018) Work-related outcomes in randomized, double blind, placebo-controlled trials in osteoarthritis – are they adequately reported in journal publications? A systematic review. Journal of Occupational Medicine and Toxicology 13:1.
Crossref
Crossref
Y. Jin, C. Smith, D. Monteith, R. Brown, A. Camporeale, T.A. McNearney, M.A. Deeg, E. Raddad, N. Xiao, A. de la Peña, A.J. Kivitz & T.J. Schnitzer. (2018) CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial. Osteoarthritis and Cartilage 26:12, pages 1609-1618.
Crossref
Crossref
Emma L Parry, Martin J Thomas & George Peat. (2018) Defining acute flares in knee osteoarthritis: a systematic review. BMJ Open 8:7, pages e019804.
Crossref
Crossref
David S. Jevsevar, Peter B. Shores, Kyle Mullen, Danielle M. Schulte, Gregory A. Brown & Deborah S. Cummins. (2018) Mixed Treatment Comparisons for Nonsurgical Treatment of Knee Osteoarthritis: A Network Meta-analysis. Journal of the American Academy of Orthopaedic Surgeons 26:9, pages 325-336.
Crossref
Crossref
Marita Cross, Ludovic Dubouis, Matthieu Mangin, David J. Hunter, Lyn March, Gillian Hawker & Francis Guillemin. (2017) Defining Flare in Osteoarthritis of the Hip and Knee: A Systematic Literature Review — OMERACT Virtual Special Interest Group. The Journal of Rheumatology 44:12, pages 1920-1927.
Crossref
Crossref
Tie P. Yamato, Chris G. Maher, Bruno T. Saragiotto, Christina Abdel Shaheed, Anne M. Moseley, Chung-Wei Christine Lin, Bart Koes & Andrew J. McLachlan. (2017) Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review. British Journal of Clinical Pharmacology 83:11, pages 2347-2355.
Crossref
Crossref
Cheuk-Yui Leung, Andrea N. Trementozzi, Yiqing Lin, Jin Xu, Erwin Irdam, J. Michael MacPhee, Min He, Shyam B. Karki, Pierre Boulas & Peter N. Zawaneh. (2017) Enteric coating of micron-size drug particles through a Würster fluid-bed process. Powder Technology 317, pages 247-252.
Crossref
Crossref
Livia Puljak, Ana Marin, Davorka Vrdoljak, Filipa Markotic, Ana Utrobicic & Peter Tugwell. (2017) Celecoxib for osteoarthritis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Crossref
Chul-Won Ha, Yong-Beom Park, Hee-Soo Kyung, Chung-Soo Han, Ki-Cheor Bae, Hong-Chul Lim, Sang-Eun Park, Myung Chul Lee, Ye-Yeon Won, Dong-Chul Lee, Sung-Do Cho, Chang-Wan Kim, Jin-Goo Kim, Joon-Soon Kang, Ju-Hong Lee, Eui-Sung Choi, Jong-Keun Seon, Woo-Suk Lee & Seong-Il Bin. (2016) Gastrointestinal safety and efficacy of long-term GCSB-5 use in patients with osteoarthritis: A 24-week, multicenter study. Journal of Ethnopharmacology 189, pages 310-318.
Crossref
Crossref
Chao Xu, Ke Gu, Yalikun Yasen & Yanjie Hou. (2016) Efficacy and Safety of Celecoxib Therapy in Osteoarthritis. Medicine 95:20, pages e3585.
Crossref
Crossref
Carmelo Scarpignato, Angel Lanas, Corrado Blandizzi, Willem F Lems, Matthias Hermann & Richard H Hunt. (2015) Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Medicine 13:1.
Crossref
Crossref
Bill H. McCarberg & Byron Cryer. (2015) Evolving Therapeutic Strategies to Improve Nonsteroidal Anti-inflammatory Drug Safety. American Journal of Therapeutics 22:6, pages e167-e178.
Crossref
Crossref
Raveendhara R. BannuruTimothy E. McAlindonMatthew C. SullivanJohn B. WongDavid M. KentChristopher H. Schmid. (2015) Effectiveness and Implications of Alternative Placebo Treatments. Annals of Internal Medicine 163:5, pages 365-372.
Crossref
Crossref
Marc C Hochberg. (2015)
Response to: ‘Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?’ by Zeng
et al
. Annals of the Rheumatic Diseases 74:9, pages e57-e57.
Crossref
Crossref
Chao Zeng, Jie Wei, Hui Li, Tuo Yang, Shu-guang Gao, Yu-sheng Li, Yi-lin Xiong, Wen-feng Xiao, Wei Luo, Tu-bao Yang & Guang-hua Lei. (2015) Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis. Scientific Reports 5:1.
Crossref
Crossref
Anthony V. Perruccio & Vinod Chandran. 2015. Osteoarthritis. Osteoarthritis
211
234
.
Julie Myers, Ronald C Wielage, Baoguang Han, Karen Price, James Gahn, Marie-Ange Paget & Michael Happich. (2014) The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskeletal Disorders 15:1.
Crossref
Crossref
Dominick J. Angiolillo, Catherine Datto, Shane Raines & Neville D. Yeomans. (2013) Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies. Journal of Thrombosis and Thrombolysis 38:1, pages 11-23.
Crossref
Crossref
Yong-Geun Park, Chul-Won Ha, Chang-Dong Han, Seong-Il Bin, Hee-Chun Kim, Young-Bok Jung & Hong-Chul Lim. (2013) A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. Journal of Ethnopharmacology 149:3, pages 816-824.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Sohita Dhillon. (2012) Fixed-dose naproxen/esomeprazole magnesium: a guide to its use to treat arthritic symptoms and reduce gastric ulcer risk. Drugs & Therapy Perspectives 28:8, pages 1-5.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Sohita Dhillon. (2012) Fixed-dose naproxen/esomeprazole magnesium: a guide to its use to treat arthritic symptoms and reduce gastric ulcer risk. Drugs & Therapy Perspectives 28:8, pages 1-5.
Crossref
Crossref
Sanford H. Roth. (2012) Coming to Terms with Nonsteroidal Anti-Inflammatory Drug Gastropathy. Drugs 72:7, pages 873-879.
Crossref
Crossref
Robin K Dore & Megan Locks. (2012) Naproxen/esomeprazole magnesium in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. International Journal of Clinical Rheumatology 7:1, pages 21-31.
Crossref
Crossref
Paul L. McCormack. (2011) Celecoxib. Drugs 71:18, pages 2457-2489.
Crossref
Crossref